These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29726372)

  • 1. Minimalism in oncology.
    The Lancet Oncology
    Lancet Oncol; 2018 May; 19(5):579. PubMed ID: 29726372
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspectives on Cost and Value in Cancer Care.
    Saltz LB
    JAMA Oncol; 2016 Jan; 2(1):19-21. PubMed ID: 26501848
    [No Abstract]   [Full Text] [Related]  

  • 3. The Value of Considering Cost, and the Cost of Not Considering Value.
    Saltz LB
    J Clin Oncol; 2016 Mar; 34(7):659-60. PubMed ID: 26668345
    [No Abstract]   [Full Text] [Related]  

  • 4. United healthcare, five oncology practices try bundled payments.
    Goozner M
    J Natl Cancer Inst; 2011 Jan; 103(1):8-10. PubMed ID: 21169535
    [No Abstract]   [Full Text] [Related]  

  • 5. Bending the cost curve in cancer care.
    Smith TJ; Hillner BE
    N Engl J Med; 2011 May; 364(21):2060-5. PubMed ID: 21612477
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted immunotherapies overtaking emerging oncology market value based growth.
    Jakovljevic MB
    J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating physician performance in oncology: moneyball becomes impactball.
    Fisch MJ; Abbruzzese JL; Hong WK
    J Oncol Pract; 2014 Jan; 10(1):79-81. PubMed ID: 24443736
    [No Abstract]   [Full Text] [Related]  

  • 8. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
    Low E;
    J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
    [No Abstract]   [Full Text] [Related]  

  • 9. [Health services research in oncology using claims data].
    Hoffmann F; Glaeske G
    Med Klin (Munich); 2010 Jun; 105(6):409-15. PubMed ID: 20582501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US Cancer Care System Ill-Equipped to Deliver New Advances to Patients.
    Rappaport M
    J Oncol Pract; 2016 May; 12(5):397. PubMed ID: 27170686
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
    Gori S; Di Maio M; Pinto C; Alabiso O; Baldini E; Barbato E; Beretta GD; Bravi S; Caffo O; Canobbio L; Carrozza F; Cinieri S; Cruciani G; Dinota A; Gebbia V; Giustini L; Graiff C; Molino A; Muggiano A; Pandoli G; Puglisi F; Tagliaferri P; Tomao S; Lunardi G; Venturini M;
    Tumori; 2013; 99(1):35-8. PubMed ID: 23548997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges, Perceptions, and Readiness of Oncology Clinicians for the MACRA Quality Payment Program.
    Nabhan C; Jeune-Smith Y; Klinefelter P; Kelly RJ; Feinberg BA
    JAMA Oncol; 2018 Feb; 4(2):252-253. PubMed ID: 29167859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value in Oncology: It Is in the Eyes of the Beholder.
    Nabhan C; Phillips EG; Feinberg BA
    J Natl Compr Canc Netw; 2019 Jan; 17(1):2-5. PubMed ID: 30659123
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dose reassessment: An answer to the high cost of drugs used in oncology?].
    Levêque D
    Bull Cancer; 2019 Sep; 106(9):719-724. PubMed ID: 31202558
    [No Abstract]   [Full Text] [Related]  

  • 15. Tackling Cost: A Prescription for Spending Wisely.
    Tempero M
    J Natl Compr Canc Netw; 2019 Jun; 17(6):633. PubMed ID: 31200360
    [No Abstract]   [Full Text] [Related]  

  • 16. [Economic evaluation in oncology].
    Schöffski O
    Med Klin (Munich); 2000 Jun; 95 Suppl 1():14-7. PubMed ID: 10941248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partnering with a payer to develop a value-based medical home pilot: a West Coast practice's experience.
    Bosserman LD; Verrilli D; McNatt W
    Am J Manag Care; 2012 May; 18(5 Spec No. 2):SP88-90. PubMed ID: 22693987
    [No Abstract]   [Full Text] [Related]  

  • 18. Seeking value as cancer drug costs soar.
    Bender E
    Cancer Discov; 2013 Aug; 3(8):833-4. PubMed ID: 23928760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
    Adams JR; Elting LS; Lyman GH; George JN; Lembersky BC; Armitage JO; Demetri GD; Bennett CL
    Am J Med; 2004 Jan; 116(1):28-34. PubMed ID: 14706663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Drugs Fund of minimal benefit.
    Burki TK
    Lancet Oncol; 2017 Jun; 18(6):e305. PubMed ID: 28483412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.